Cytarabine/etoposide

Cytarabine/etoposide Reactions 1680, p106 - 2 Dec 2017 Vitreous haemorrhage and hypokalaemia: 2 case report In a retrospective observational study of 46 patients, two patients [ages and sexes not stated] were described, who developed vitreous haemorrhage (one patient) and hypokalaemia (one patient) during treatment with etoposide and cytarabine [duration of treatments to reaction onsets and outcomes not stated]. The patients, who had a history of lymphoma, were scheduled to undergo peripheral blood stem cell harvest. The stem cell mobilisation was carried out with continuous infusion of etoposide 100 mg/m /day and continuous infusion of cytarabine 100 mg/m /day, both were administered from day one to day four. However, one patient developed grade III vitreous haemorrhage and one patient developed grade III hypokalaemia. Author comment: "Only two patients developed grade 3 non-hematological adverse events (one vitreous hemorrhage and one hypokalemia). . .Other non-hematological severe adverse events were rarely observed; therefore, the toxicity of the EC regimen was acceptable on the whole." Koyama D, et al. Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: A single-center, retrospective, observational study. Japanese Journal of Clinical Oncology 47: 820-825, No. 9, Sep 2017. Available from: URL: http://doi.org/10.1093/jjco/hyx076 - Japan 803284128 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Cytarabine/etoposide

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/cytarabine-etoposide-CU9qYvn9St
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39037-8
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p106 - 2 Dec 2017 Vitreous haemorrhage and hypokalaemia: 2 case report In a retrospective observational study of 46 patients, two patients [ages and sexes not stated] were described, who developed vitreous haemorrhage (one patient) and hypokalaemia (one patient) during treatment with etoposide and cytarabine [duration of treatments to reaction onsets and outcomes not stated]. The patients, who had a history of lymphoma, were scheduled to undergo peripheral blood stem cell harvest. The stem cell mobilisation was carried out with continuous infusion of etoposide 100 mg/m /day and continuous infusion of cytarabine 100 mg/m /day, both were administered from day one to day four. However, one patient developed grade III vitreous haemorrhage and one patient developed grade III hypokalaemia. Author comment: "Only two patients developed grade 3 non-hematological adverse events (one vitreous hemorrhage and one hypokalemia). . .Other non-hematological severe adverse events were rarely observed; therefore, the toxicity of the EC regimen was acceptable on the whole." Koyama D, et al. Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: A single-center, retrospective, observational study. Japanese Journal of Clinical Oncology 47: 820-825, No. 9, Sep 2017. Available from: URL: http://doi.org/10.1093/jjco/hyx076 - Japan 803284128 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off